AngelEye Health Secures Additional $9 Million to Accelerate Innovation in Neonatal and Pediatric Care

New investment fuels the continued growth of its advanced NICU and Pediatric solutions, accelerating AIVision adoption

NASHVILLE, Tenn.--(BUSINESS WIRE)--AngelEye Health, a leader in neonatal and pediatric services, today announced the closing of a $9 million Series C funding round. In addition to the equity financing, AngelEye has secured a complementary debt facility from Live Oak Bank to strategically extend the company’s growth capital. The combined funding will enable AngelEye to accelerate product innovation, expand its commercial footprint, and further advance its mission to transform neonatal and pediatric inpatient units into intelligent, connected environments optimized for care delivery, efficiency, and family empowerment.

The round was led by existing investor Mountain Group Partners, with continued support from Brad Whitmore and additional existing investors. AngelEye is also pleased to welcome Nationwide Children’s Hospital as a new investor, underscoring a shared commitment to improving outcomes for vulnerable infants. In conjunction with the investment, Luke Brown, Vice President of Finance and Treasury at Nationwide Children’s Hospital will join AngelEye’s Board of Directors as an observer.

“AngelEye’s mission to empower families and equip care teams in the NICU and pediatric settings aligns strongly with our goals as a pediatric health leader,” said Mr. Brown.

The company is proud to announce that with the increasing adoption of its platform, AngelEye now provides services to over 350 hospitals who serve approximately 20% of the NICU families across the United States. Additionally, the Series C announcement follows several significant 2025 milestones for AngelEye, including its fourth consecutive appearance on the Inc. 5000 list of America’s fastest-growing private companies, recognition as an Inc. Power Partner, and the achievement of SOC II Type 2 certification.

“Our team has remained focused on one mission: helping hospitals provide comprehensive support for clinical teams and families alike, equipping them with the tools they need to stay connected, confident, and informed throughout the NICU journey,” said Christopher Rand, CEO of AngelEye Health. “This funding gives us the ability to bring AIVision to market while continuing to scale the solutions that have already made us a trusted partner to hundreds of hospitals nationwide.”

AngelEye’s platform has become a mainstay in NICU and PICU environments, enabling real-time family connection through secure livestream video, streamlining feeding workflows and documentation with MilkTracker, and guiding families through discharge readiness with NICU2Home. With the addition of AIVision, the company is advancing its value proposition by providing care teams with earlier, AI-driven insights, reinforcing its role as a critical partner in patient safety, family engagement, and operational efficiency.

For more information about AngelEye Health, visit www.angeleyehealth.com.

About AngelEye Health

AngelEye Health is the leading provider of innovative technology solutions dedicated to transforming neonatal and pediatric care. Trusted by over 350 hospitals globally, AngelEye equips care teams with AI-driven tools designed to streamline workflows, reduce length of stay, minimize errors, and optimize resource allocation. Its comprehensive suite, including CameraSystem for family engagement, MilkTracker for precise feeding management, NICU2Home for efficient discharge planning, and EDNA for proactive risk identification, supports care teams and families at every step of the NICU journey. With a commitment to continuous innovation, AngelEye Health is shaping the NICU of the future, empowering families, enhancing clinical efficiency, and delivering measurable improvements in patient outcomes. To learn more, visit angeleyehealth.com.